People who have not taken HIV meds for at least 90 days will drink pomegranate juice or placebo juice daily for 10 to 18 weeks to study its effect on the heart, quality of life, and HIV viral load.
People who have taken HIV drugs will receive infusions of ibalizumab (a monoclonal antibody designed to block HIV entry into CD 4 cells) once or twice a month for 48 weeks, along with other HIV drugs.
People 18 and older who have persistent diarrhea will take crofelemer (a new anti-diarrhea drug) or placebo tablets for 6 weeks. Then everyone will take crofelemer for 5 months.
People with insulin resistance will take Avandia or Serostim (growth hormone), or both for 6 months to see how they affect blood sugar, insulin levels, and body shape.
People who have developed resistance to Reyataz will come in for one day of blood tests to study the I50L mutation.
People who have taken HIV meds before will take this new CCR5 inhibitor for 10 days with no other HIV meds.
People who have not taken HIV meds before will take this new CCR5 inhibitor with other HIV meds for 48 weeks.
For more information on these trials, contact us at 212-924-3934, ext. 121.
Want to read more articles in the Winter 2008/2009 issue of Achieve? Click here.
This article was provided by ACRIA and GMHC. It is a part of the publication Achieve. Visit ACRIA's website and GMHC's website to find out more about their activities, publications and services.